, Volume 35, Supplement 2, pp 127–132 | Cite as

Cefotaxime Lavage in Children Undergoing Appendicectomy

  • T. A. McAllister
  • A. H. B. Fyfe
  • D. G. Young
  • P. A. M. Raine
Section 3: Newer Experiences with Cefotaxime in Prophylaxis


In an attempt to reduce postoperative sepsis, a series of randomised, double-blind studies was begun in 1982, using cefotaxime as backbone therapy. Up to 1985 (stages I and II), the best results were obtained using a combination of cefotaxime (75 mg/kg intravenously in 3 doses at 12-hourly intervals) plus metronidazole (10 mg/kg intravenously in 3 doses), both drugs administered 1 hour before surgery (preoperatively) or at anaesthetic induction (perioperatively). In 300 consecutive cases, the wound infection rates were 1% in uncomplicated acute appendicitis and 5% in perforated/gangrenous appendices.

The present study (stage III) reports the findings in 401 consecutive patients: 215 treated with the above regimen, either pre-or perioperatively (group 1) and 186 who additionally had peritoneal lavage with cefotaxime 2 g/L during surgery (group 2). There were 16 wound infections overall, 2 among patients administered prophylaxis preoperatively and 14 in those administered prophylaxis perioperatively. All produced mixed cultures, with Escherichia coli, Streptococcus milleri and Bacteroides fragilis predominating. The overall figures for postoperative sepsis are 12/215 (5.6%) in the non-lavage group and 8/186 (4.3%) in the lavage group. Among patients with a perforated and/or gangrenous appendix, the wound infection rate was 8/72 (11.1% ) in the non-lavage group (group 1) and 4/66 (6.1%) in the lavage group (group 2). Each group had 2 cases of pelvic abscess.


Appendicitis Metronidazole Cefotaxime Acute Appendicitis Peritoneal Lavage 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Berne TV, Yellin AW, Appleman MD, Heseltine PNR. Antibiotic management of surgically treated gangrenous or perforated appendicitis. American Journal of Surgery 144: 8–13, 1982PubMedCrossRefGoogle Scholar
  2. Burke JF. The effective period of preventive antibiotic action in experimental incisions and dermal lesions. Surgery 50: 161–168, 1961PubMedGoogle Scholar
  3. Campbell WN. Prophylaxis of infection after appendicectomy: a survey of current clinical practice. British Medical Journal 281: 1597–1600, 1980PubMedCrossRefGoogle Scholar
  4. Chiam HL, Chee CP, Cheak KC, Semasundaram K, Putchu-cheary SD. The prevention of postappendectomy sepsis by metronidazole and cotrimoxazole: a controlled double-blind trial. Australian and New Zealand Journal of Surgery 53: 421–425, 1983PubMedCrossRefGoogle Scholar
  5. Danish Multicenter Study Group. A Danish multicenter study: cefoxitin versus ampicillin and metronidazole in perforated appendicitis. British Journal of Surgery 71: 144–146, 1984CrossRefGoogle Scholar
  6. Di Piro JT, Bivins BA, Record KE, Bil RM, Gaiffen WO. The prophylactic use of antimicrobials in surgery. Current Problems in Surgery 20: 76–132, 1983Google Scholar
  7. Donovan IA, Ellis D, Gatehouse D, Little G, Grimly R, et al. One dose antibiotic prophylaxis against wound infection after appendicectomy. A randomized trial of clindamycin, cefazolin sodium and a placebo. British Journal of Surgery 66: 193–196, 1979PubMedCrossRefGoogle Scholar
  8. Evans M, Pollock AV. A score system for evaluating random control clinical trials of prophylaxis of abdominal surgical wound infection. British Journal of Surgery 72: 256–260, 1985PubMedCrossRefGoogle Scholar
  9. Favre JP, Bouchet Y, Clotteau JE, Hypousteguy L, Marchal G, et al. Prophylactic use of cefotaxime in colonie and rectal surgery. Journal of Antimicrobial Chemotherapy 14 (Suppl. B): 247–253, 1984PubMedGoogle Scholar
  10. Fine M, Busuttil RW. Acute appendicitis: efficacy of prophylactic preoperative antibiotic in the reduction of septic morbidity. American Journal of Surgery 135: 210–212, 1978PubMedCrossRefGoogle Scholar
  11. Giacomantonio M, Bortolussi R, Gillis DA. Should prophylactic antibiotics be given perioperatively in acute appendicitis without perforation? Canadian Journal of Surgery 25: 555–556, 1982Google Scholar
  12. Gilmore OJA, Martin TDM. Etiology and prevention of wound infection in appendectomy. British Journal of Surgery 61: 281–287, 1974PubMedCrossRefGoogle Scholar
  13. Keighley MRB. Indications for chemoprophylaxis. In Karran (Ed.) Controversies in Surgical Sepsis, pp. 87–93, Praeger, New York, 1980Google Scholar
  14. Lau WY, Fan ST, Chu KW, Suen HC, Yiu TF, et al. Randomized prospective, and double-blind trial of new beta-lactams in the treatment of appendicitis. Antimicrobial Agents and Chemotherapy 28: 639–642, 1985PubMedCrossRefGoogle Scholar
  15. Lau WY, Fan ST, Chu KW, Yip WC, Yiu TF, et al. Cefoxitin versus gentamicin and metronidazole in prevention of post-appendicectomy sepsis: a randomized prospective trial. Journal of Antimicrobial Chemotherapy 18: 613–619, 1986PubMedCrossRefGoogle Scholar
  16. Leigh DA, Simmons K, Norman E. Bacterial flora of the appendix fossa in appendicitis and postoperative wound infection. Journal of Clinical Pathology 27: 997–1000, 1974PubMedCrossRefGoogle Scholar
  17. Louie TJ, Blanchard R, Yaffe C, Lertzman J, McLeod J. Randomized, double-blind comparison of cefotaxime, cefoxitin, cefazolin or placebo as prophylaxis during gastric, small bowel or complicated biliary surgery. Journal of Antimicrobial Chemotherapy 14 (Suppl. B): 255–262, 1984PubMedGoogle Scholar
  18. Magarey CJ, Chant ABD, Richford CRK, Magarey JR. Peritoneal drainage and systemic antibiotics after appendectomy. Lancet II: 179–182, 1971CrossRefGoogle Scholar
  19. McAllister TA, Fyfe AHB, Young DG, Raine PAM. Randomized double-blind studies of cefotaxime in children undergoing appendicectomy. In Neu (Ed.) Proceedings of the 14th International Congress of Chemotherapy, Kyoto, June 23–28, 1985, pp. 69–75, Excerpta Medica, Amsterdam, 1985Google Scholar
  20. Miles AA, Miles EM, Burke J. The value and duration of defence reaction of the skin to the primary lodgement of bacteria. British Journal of Experimental Pathology 38: 79–96, 1957PubMedGoogle Scholar
  21. Morris WT, Innes DB, Richardson RA, Lee AJ, Ellis-Pegler RB. The prevention of postappendicectomy sepsis by metronidazole and cefazolin: a controlled double-blind trial. Australian and New Zealand Journal of Surgery 50: 429–433, 1980PubMedCrossRefGoogle Scholar
  22. Neu HC, Aswapokee N, Aswapokee P, Fu KP. HR 756, a new cephalosporin active against Gram-positive and Gram-negative bacteria. Antimicrobial Agents and Chemotherapy 15: 273–278, 1979PubMedCrossRefGoogle Scholar
  23. Richmond MH. Beta-lactamase stability of cefotaxime. Journal of Antimicrobial Chemotherapy 6 (Suppl. A): 13–17, 1980PubMedGoogle Scholar
  24. Sanders CC. Emerging problems of resistance to the newer cephalosporins: clinical significance. Internal Medicine for the Specialist 5: 1–5, 1984Google Scholar
  25. Selkon JB. Use and abuse of chemoprophylaxis. In Evans (Ed.) Serious infections — treatment and prevention, pp. 45–46, Update Books, London, 1983Google Scholar
  26. Shah PM, Troche G, Stillew. In vitro activity of HR 756, a new cephalosporin compound. Journal of Antibiotics 31: 1170–1174, 1978PubMedCrossRefGoogle Scholar
  27. Smith CR, Ambinder R, Lipsky JJ, Petty BG, Israel E, et al. Cefotaxime compared with nafcillin plus tobramycin for serious bacterial infections. Annals of Internal Medicine 101: 469–477, 1984PubMedGoogle Scholar
  28. Strachan CJL. Systemic prophylaxis. In Karran (Ed.) Controversies in Surgical Sepsis, pp. 159–168, Praeger, New York, 1980Google Scholar
  29. Wise R, Wills PJ, Andrews JM, Bedford KA. Activity of the cefotaxime metabolite compared with those of cefotaxime and other cephalosporins. Antimicrobial Agents and Chemotherapy 17: 84–86, 1980PubMedCrossRefGoogle Scholar

Copyright information

© ADIS Press Limited 1988

Authors and Affiliations

  • T. A. McAllister
    • 1
  • A. H. B. Fyfe
    • 2
  • D. G. Young
    • 2
  • P. A. M. Raine
    • 2
  1. 1.Department of MicrobiologyRoyal Hospital for Sick ChildrenGlasgowUK
  2. 2.Department of Paediatric SurgeryRoyal Hospital for Sick ChildrenGlasgowUK

Personalised recommendations